View in EDS HTML Full Text PDF Full Text

A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death.

Saved in:
Bibliographic Details
Title: A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death.
Authors: Ray A; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. arghya_ray@dfci.harvard.edu., Du T; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Wan X; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Song Y; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Pillai SC; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Musa MA; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Fang T; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Moore J; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Blank B; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Du X; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Chen X; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Warne R; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Sutimantanapi D; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Lui F; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Zavorotinskaya T; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Colas C; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Friedman L; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Junttila MR; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA., Chauhan D; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Dharminder_Chauhan@dfci.harvard.edu., Anderson KC; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Kenneth_Anderson@dfci.harvard.edu.
Source: Blood cancer journal [Blood Cancer J] 2024 Apr 09; Vol. 14 (1), pp. 58. Date of Electronic Publication: 2024 Apr 09.
Publication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38594241
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ray+A%22">Ray A</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. arghya_ray@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Du+T%22">Du T</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wan+X%22">Wan X</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Song+Y%22">Song Y</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pillai+SC%22">Pillai SC</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Musa+MA%22">Musa MA</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fang+T%22">Fang T</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moore+J%22">Moore J</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Blank+B%22">Blank B</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Du+X%22">Du X</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Warne+R%22">Warne R</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sutimantanapi+D%22">Sutimantanapi D</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lui+F%22">Lui F</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zavorotinskaya+T%22">Zavorotinskaya T</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Colas+C%22">Colas C</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Friedman+L%22">Friedman L</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Junttila+MR%22">Junttila MR</searchLink>; ORIC Pharmaceuticals, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chauhan+D%22">Chauhan D</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Dharminder_Chauhan@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Anderson+KC%22">Anderson KC</searchLink>; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Kenneth_Anderson@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2024 Apr 09; Vol. 14 (1), pp. 58. <i>Date of Electronic Publication: </i>2024 Apr 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38594241
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-024-01019-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 58
    Titles:
      – TitleFull: A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ray A
      – PersonEntity:
          Name:
            NameFull: Du T
      – PersonEntity:
          Name:
            NameFull: Wan X
      – PersonEntity:
          Name:
            NameFull: Song Y
      – PersonEntity:
          Name:
            NameFull: Pillai SC
      – PersonEntity:
          Name:
            NameFull: Musa MA
      – PersonEntity:
          Name:
            NameFull: Fang T
      – PersonEntity:
          Name:
            NameFull: Moore J
      – PersonEntity:
          Name:
            NameFull: Blank B
      – PersonEntity:
          Name:
            NameFull: Du X
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Warne R
      – PersonEntity:
          Name:
            NameFull: Sutimantanapi D
      – PersonEntity:
          Name:
            NameFull: Lui F
      – PersonEntity:
          Name:
            NameFull: Zavorotinskaya T
      – PersonEntity:
          Name:
            NameFull: Colas C
      – PersonEntity:
          Name:
            NameFull: Friedman L
      – PersonEntity:
          Name:
            NameFull: Junttila MR
      – PersonEntity:
          Name:
            NameFull: Chauhan D
      – PersonEntity:
          Name:
            NameFull: Anderson KC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 04
              Text: 2024 Apr 09
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1